Home
Overview
Programs
Technology
Publications Business Developement Press Contact
 
8/14/08 Dr. Robert Stein, MD, PhD, Named CEO of KineMed
1/1/08 Repositioning Idle Drugs via Systematic Serendipity; Systems-based Approaches for Boosting Stalled Drugs
10/11/07 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
8/28/07 KineMed to Collaborate with Merck KGaA to Validate New Applications for Drug Development Candidates; Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds in Merck KGaA Pipeline
  more...


Publications

General Articles of Interest | Measurement of Cell Proliferation | HIV/AIDS T-Cell Kinetics and Lifespan | Measurement of Protein Synthesis and Degradation | Fuel Selection/Carbohydrate, Lipid and Cholesterol Metabolism | Advances in Mass Spectrometry Applications | Toxicology


General Articles of Interest

Home | Overview | Programs | Technology | Publications | Business Development | Press | Contact

All contents © 2006 KineMed, Inc.